ABT vs JKHY · P/E 25, rev $44.33B vs P/E 30, rev $2.54B
Abbott Laboratories (ABT) versus Jack Henry & Associates Inc (JKHY) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Jack Henry & Associates Inc (JKHY) is a information technology services company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported JKHY revenue for 2026-06-30 was $2.54B. Net income was $502.8M. Revenue was up 7.1% from 2025-06-30 to 2026-06-30. JKHY currently screens at market cap $12.76B and trailing P/E 29.8.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. JKHY currently screens at market cap $12.76B and trailing P/E 29.8.
Not investment advice. Open the ABT and JKHY stock pages for the full models.
Not investment advice.